Aspen Pharmacare Revenue 2017-2023 | APNHY
Aspen Pharmacare annual/quarterly revenue history and growth rate from 2017 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aspen Pharmacare revenue for the quarter ending June 30, 2023 was $M, a NAN% increase year-over-year.
- Aspen Pharmacare revenue for the twelve months ending June 30, 2023 was $0M, a NAN% increase year-over-year.
- Aspen Pharmacare annual revenue for 2023 was $2.296B, a 9.62% decline from 2022.
- Aspen Pharmacare annual revenue for 2022 was $2.54B, a 3.16% increase from 2021.
- Aspen Pharmacare annual revenue for 2021 was $2.462B, a 1.07% decline from 2020.
Aspen Pharmacare Annual Revenue
(Millions of US $) |
| 2023 |
$2,296 |
| 2022 |
$2,540 |
| 2021 |
$2,462 |
| 2020 |
$2,489 |
| 2019 |
$2,740 |
| 2018 |
$3,327 |
| 2017 |
$3,028 |
| 2016 |
$2,471 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Revenue
(Millions of US $) |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.038B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
